| Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma M Sade-Feldman, RW Jenkins, A Portell, PH Lizotte, AR Aref, JP Eliane, ... Cell 175 (4), 998-1013. e20, 2018 | 1651 | 2018 |
| Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems M Karimi, Aref, Amir R, Haghani, S Bahrami, MR Hamblin Chemical Society Reviews 45 (5), 1457-1501, 2016 | 1445 | 2016 |
| Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance L Mashouri, H Yousefi, AR Aref, A Ahadi, F Molaei, SK Alahari Molecular cancer 18, 1-14, 2019 | 1274 | 2019 |
| CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation J Deng, ES Wang, RW Jenkins, AR Aref, E Ivanova, CP Paweletz, ... Cancer Discovery, CD-17-0915, 2017 | 672 | 2017 |
| STK11/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment S Koyama, EA Akbay, YY Li, AR Aref, F Skoulidis, GS Herter-Sprie, ... Cancer research 76 (5), 999-1008, 2016 | 579 | 2016 |
| Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing MRH Mirza Ali Mofazzal Jahromi, Parham Sahandi Zangabad, Seyed Masoud ... Advanced drug delivery reviews 123, 33-64, 2018 | 524 | 2018 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 521 | 2018 |
| Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor KKW Camilla L. Christensen, Amir R. Aref, David A. Barbie, Nathanael S. Gray ... Cancer Cell 26 (6), 909-922, 2014 | 472 | 2014 |
| Personalized Cancer Medicine: An Organoid Approach HA Es, AR Aref, M Vosough, H Baharvand Trends in Biotechnology, 2018 | 285 | 2018 |
| Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses I Cañadas, R Thummalapalli, RW Jenkins, AR Aref, T Hagan, S Koyama, ... Nature Medicine, 1, 2018 | 284 | 2018 |
| 3D microfluidic ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade AR Aref, M Campisi, E Ivanova, A Portell, D Larios, BP Piel, N Mathur, ... Lab on a Chip 18 (20), 3129-3143, 2018 | 258 | 2018 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 176 (1), 404, 2019 | 235 | 2019 |
| Status and future scope of plant-based green hydrogels in biomedical engineering R Mohammadinejad, H Maleki, E Larrañeta, AR Fajardo, AB Nik, ... Applied Materials Today 16, 213-246, 2019 | 217 | 2019 |
| Screening therapeutic EMT blocking agents in a three-dimensional microenvironment AR Aref, RYJ Huang, W Yu, KN Chua, W Sun, TY Tu, J Bai, WJ Sim, ... Integrative Biology 5 (2), 381-389, 2013 | 210 | 2013 |
| Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit Z Zhu, AR Aref Cancer Discovery 4 (4), 452-465, 2014 | 209 | 2014 |
| Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors L Tan, AR Aref, M Rusan, SJ Zhu, Y Zhang, D Ercan, RG Liao, ... Proceedings of the National Academy of Sciences 111 (45), E4869-E4877, 2014 | 207 | 2014 |
| Carbon nanotubes part II: a remarkable carrier for drug and gene delivery MRH Mahdi Karimi, Navid Solati, Amir Ghasemi, Amir R Aref, Mohammad Amiri ... Expert opinion on drug delivery, 1-17, 2015 | 200* | 2015 |
| Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance H Yousefi, M Maheronnaghsh, F Molaei, L Mashouri, A Reza Aref, ... Oncogene 39 (5), 953-974, 2020 | 198 | 2020 |
| New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities M Ashrafizadeh, S Mirzaei, F Hashemi, A Zarrabi, A Zabolian, H Saleki, ... Biomedicine & Pharmacotherapy 141, 111824, 2021 | 163 | 2021 |
| Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects AJ Abadi, S Mirzaei, MK Mahabady, F Hashemi, A Zabolian, F Hashemi, ... Phytotherapy Research 36 (1), 189-213, 2022 | 161 | 2022 |
mahdi karimiIran University of Medical ScienceE-mailová adresa ověřena na: iums.ac.ir
